
WGS · NASDAQ
GeneDx Holdings Corp.
$63.43 +2.30 (+3.76%)
Company overview
GeneDx Holdings Corp. is a patient-centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and define optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, Connecticut.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Exchange
- NASDAQ
- Market cap
- $1.9B
- Employees
- 1,000
- Headquarters
- Stamford, CT
- Website
- genedx.com
- CEO
- Katherine A. Stueland
- Listed
- November 4, 2020
- P/E
- -23.80
- Dividend yield
- 0.00%
Company financials
- Revenue
- $443M
- Gross profit
- $303M
- Operating income
- -$34.2M
- EBITDA
- -$48.5M
- Net income
- -$77.8M
- EPS
- -$2.66
- Total assets
- $506M
- Total debt
- $168M
- Gross margin
- 68.35%
- Net margin
- -17.58%
- Earnings yield
- -4.20%
No geographic segmentation.
Showing FY 2025